Yuan Gao
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The global patent landscape of the drugs for treating Alzheimer's disease from 2014-2023.
Journal: BMC neurology
Published: May 10, 2024
Presenilin deficiency enhances tau phosphorylation and its secretion.
Journal: Journal of neurochemistry
Published: December 11, 2023
Presenilin 1 deficiency impairs Aβ42-to-Aβ40- and angiotensin-converting activities of ACE.
Journal: Frontiers in aging neuroscience
Published: November 14, 2022
Aβ42 treatment of the brain side reduced the level of flotillin from endothelial cells on the blood side via FGF-2 signaling in a blood-brain barrier model.
Journal: Molecular brain
Published: September 22, 2022
Apolipoprotein E4 inhibits γ-secretase activity via binding to the γ-secretase complex.
Journal: Journal of neurochemistry
Published: August 25, 2022
Presenilin Deficiency Increases Susceptibility to Oxidative Damage in Fibroblasts.
Journal: Frontiers in aging neuroscience
Published: March 23, 2022
Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: October 10, 2021
Cholesterol Regulates Exosome Release in Cultured Astrocytes.
Journal: Frontiers in immunology
Published: June 11, 2021
High temperature promotes amyloid β-protein production and γ-secretase complex formation via Hsp90.
Journal: The Journal of biological chemistry
Published: April 11, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026